Mark Eccleston

Mark Eccleston has extensive experience in the field of polymer chemistry and biomedical applications. Mark has worked in various roles such as Senior Consultant, Chief Technology Officer, Business Development Director, and Managing Director in companies like VALIRX PLC, Volition, OncoLytika, and Vivamer. Mark has also been involved in academic research and has a strong track record of developing commercial applications in areas such as drug delivery, imaging, and responsive hydrogels. Mark holds an MBA from the University of Dundee, a PhD in Polymer Chemistry for Biomedical Applications from Aston University, and a BSc in Chemistry from Aston University.